| Primary |
| Chronic Obstructive Pulmonary Disease |
39.3% |
| Asthma |
22.6% |
| Product Used For Unknown Indication |
7.9% |
| Dyspnoea |
7.1% |
| Emphysema |
5.4% |
| Bronchitis |
3.4% |
| Wheezing |
2.3% |
| Pneumonia |
1.7% |
| Bronchiectasis |
1.1% |
| Hypersensitivity |
1.1% |
| Pulmonary Fibrosis |
1.1% |
| Condition Aggravated |
0.8% |
| Convulsion |
0.8% |
| Cough |
0.8% |
| Nasopharyngitis |
0.8% |
| Respiratory Disorder |
0.8% |
| Respiratory Distress |
0.8% |
| Upper Respiratory Tract Infection |
0.8% |
| Dermal Cyst |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
|
| Pneumonia |
14.5% |
| Tremor |
9.2% |
| Wheezing |
7.6% |
| White Blood Cell Count Increased |
7.6% |
| Medication Error |
5.3% |
| Respiratory Distress |
5.3% |
| Vomiting |
5.3% |
| Weight Increased |
5.3% |
| Convulsion |
4.6% |
| Respiratory Failure |
4.6% |
| Myocardial Infarction |
3.8% |
| Rash |
3.8% |
| Thrombosis |
3.8% |
| Condition Aggravated |
3.1% |
| Death |
3.1% |
| Pharmaceutical Product Complaint |
3.1% |
| Treatment Noncompliance |
3.1% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Heart Rate Increased |
2.3% |
| Nausea |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
22.6% |
| Asthma |
18.8% |
| Chronic Obstructive Pulmonary Disease |
17.6% |
| Drug Use For Unknown Indication |
14.5% |
| Bronchitis |
2.4% |
| Pneumonia |
2.2% |
| Dyspepsia |
2.1% |
| Emphysema |
2.1% |
| Bronchiectasis |
2.0% |
| Atrial Fibrillation |
1.8% |
| Hypersensitivity |
1.8% |
| Heart Rate Increased |
1.7% |
| Respiratory Disorder |
1.7% |
| Dyspnoea |
1.5% |
| Hypertension |
1.4% |
| Lung Disorder |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Depression |
1.1% |
| Interstitial Lung Disease |
1.1% |
| Multiple Myeloma |
1.0% |
|
| Tremor |
12.2% |
| Pneumonia |
8.2% |
| Pyrexia |
7.5% |
| Medication Error |
6.8% |
| Wheezing |
6.8% |
| Weight Increased |
6.1% |
| Drug Ineffective |
4.8% |
| Stomatitis |
4.8% |
| Swelling Face |
4.8% |
| Asthma |
4.1% |
| Nervousness |
4.1% |
| Product Quality Issue |
4.1% |
| Weight Decreased |
4.1% |
| Dyspnoea |
3.4% |
| Fatigue |
3.4% |
| Rash |
3.4% |
| Respiratory Failure |
3.4% |
| Abdominal Pain |
2.7% |
| Atrial Flutter |
2.7% |
| Death |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.0% |
| Drug Use For Unknown Indication |
19.4% |
| Asthma |
16.6% |
| Chronic Obstructive Pulmonary Disease |
7.9% |
| Hypertension |
3.2% |
| Pain |
3.1% |
| Hypersensitivity |
2.8% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Anxiety |
1.8% |
| Depression |
1.7% |
| Dyspnoea |
1.4% |
| Cardiac Disorder |
1.1% |
| Diabetes Mellitus |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Emphysema |
1.0% |
| Atrial Fibrillation |
1.0% |
| Osteoporosis |
0.9% |
| Prophylaxis |
0.9% |
| Nausea |
0.9% |
| Pulmonary Arterial Hypertension |
0.9% |
|
| Vomiting |
10.5% |
| Dyspnoea |
9.1% |
| Wheezing |
8.4% |
| Pneumonia |
7.1% |
| Weight Decreased |
6.7% |
| Weight Increased |
6.1% |
| Death |
5.4% |
| Asthma |
4.8% |
| Drug Ineffective |
4.7% |
| Pulmonary Embolism |
4.3% |
| Nausea |
3.9% |
| Pain |
3.6% |
| Tremor |
3.5% |
| Product Quality Issue |
3.3% |
| Vision Blurred |
3.3% |
| Pruritus |
3.3% |
| Urinary Tract Infection |
3.3% |
| Urticaria |
3.2% |
| Anaphylactic Reaction |
3.0% |
| Oedema Peripheral |
2.6% |
|
| Interacting |
| Chronic Obstructive Pulmonary Disease |
37.5% |
| Emphysema |
18.8% |
| Smoking Cessation Therapy |
12.5% |
| Asthma |
9.4% |
| Rhinitis |
6.3% |
| Ex-smoker |
3.1% |
| Ex-tobacco User |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Headache |
3.1% |
| Rhinitis Allergic |
3.1% |
|
| Weight Increased |
45.5% |
| Dyspnoea |
18.2% |
| Dizziness |
9.1% |
| Drug Ineffective |
9.1% |
| Sleep Disorder |
9.1% |
| Throat Tightness |
9.1% |
|
